Inhaled drug useful in preventing flu

July 06, 1999

EDITORS: This news release is being issued in conjunction with separate news releases by JAMA and Glaxo Wellcome Inc.

ANN ARBOR---An antiviral drug administered once daily during flu outbreaks may be useful in preventing type A and B influenza, according to a new study by a University of Michigan School of Public Health professor. The study appears in the July 7 issue of the Journal of the American Medical Association (JAMA).

Dr. Arnold S. Monto and colleagues studied the use of the drug zanamivir as a preventative for the flu. A total of 1,107 healthy adults from Ann Arbor and Columbia, Mo., participated in a study in which half received a placebo and half inhaled 10 milligrams of the drug zanamivir once a day for four weeks during local flu outbreaks.

"Zanamivir is the first of a class of antiviral drugs that inhibit both type A and B influenza. Vaccines are effective and should be used, but there are situations in which we need to have antiviral drugs for prevention. Taken once a day, zanamivir is very effective in preventing of influenza and is definitely safe. These drugs are especially useful when we have outbreaks caused by both type A and B viruses," Monto said.

The drug was found to be 67 percent effective in preventing laboratory-confirmed clinical influenza infection. It was found to be 84 percent effective in preventing laboratory-confirmed illnesses with fever. Of the people studied, 14 percent had received a flu vaccination prior to participating in the trial.

Zanamivir has been demonstrated to be effective in clinical trials in shortening the duration and reducing the severity of type A and B flu.

The authors write that use of drugs as a preventative for flu as an adjunct to vaccination has been considered useful in specific situations and will continue to be the case. "One of these situations was exhibited in 1997-98, when a change in the circulating virus limited the efficacy of the vaccine. Another would be when a person in the risk groups recommended for vaccination is found to be unvaccinated by medical personnel after influenza transmission has started. In this case, vaccine could be administered and the drug given and continued for at least the limited period while antibody develops."

To date, there have been two antiviral drugs--amantadine and rimantadine---found to be effective in preventing the flu. However, the researchers say there have been concerns about those drugs. "Concerns raised included the lack of effectiveness against type B viruses, occurrence of adverse effects mainly related to amantadine, and the rapid development of resistance to both agents," the authors write.

This study was supported financially by Glaxo Wellcome Inc., Research Triangle Park, N.C.

University of Michigan

Related Influenza Articles from Brightsurf:

Predicting influenza epidemics
Researchers at Linköping University, Sweden, have developed a unique method to predict influenza epidemics by combining several sources of data.

Common cold combats influenza
As the flu season approaches, a strained public health system may have a surprising ally -- the common cold virus.

Scent-sensing cells have a better way to fight influenza
Smell receptors that line the nose get hit by Influenza B just like other cells, but they are able to clear the infection without dying.

New antivirals for influenza and Zika
Leuven researchers have deployed synthetic amyloids to trigger protein misfolding as a strategy to combat the influenza A and Zika virus.

Assessment of deaths from COVID-19, seasonal influenza
Publicly available data were used to analyze the number of deaths from seasonal influenza deaths compared with deaths from COVID-19.

Obesity promotes virulence of influenza
Obesity promotes the virulence of the influenza virus, according to a study conducted in mice published in mBio, an open-access journal of the American Society for Microbiology.

Influenza: combating bacterial superinfection with the help of the microbiota
Frenc researchers and from Brazilian (Belo Horizonte), Scottish (Glasgow) and Danish (Copenhagen) laboratories have shown for the first time in mice that perturbation of the gut microbiota caused by the influenza virus favours secondary bacterial superinfection.

Chemists unveil the structure of an influenza B protein
MIT chemists have discovered the structure of an influenza B protein called BM2, a finding that could help researchers design drugs that block the protein and help prevent the virus from spreading.

How proteins help influenza A bind and slice its way to cells
Researchers have provided new insight on how two proteins help influenza A virus particles fight their way to human cells.

Eating elderberries can help minimize influenza symptoms
Conducted by Professor Fariba Deghani, Dr. Golnoosh Torabian and Dr.

Read More: Influenza News and Influenza Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to